Rivaroxaban versus warfarin in nonvalvular atrial fibrillation MR Patel, KW Mahaffey, J Garg, G Pan, DE Singer, W Hacke, G Breithardt, ... New England Journal of Medicine, 2011 | 11844 | 2011 |
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 348 (9038), 1329-1339, 1996 | 7119* | 1996 |
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind … HC Diener, J Bogousslavsky, LM Brass, C Cimminiello, L Csiba, M Kaste, ... Lancet 364 (9431), 331-337, 2004 | 2626 | 2004 |
The International Stroke Trial (IST): A Randomised Trial of Aspirin, Subcutaneous Heparin, Both, or Neither Among 19,435 Patients with Acute Ischaemic Stroke KSL Wong, ISTC Group The Lancet 349 (9065), 1569-1581, 1997 | 1867 | 1997 |
Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke C Marini, F De Santis, S Sacco, T Russo, L Olivieri, R Totaro, A Carolei Stroke 36, 1115-1119, 2005 | 1331 | 2005 |
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke RL Sacco, HC Diener, S Yusuf, D Cotton, S Ôunpuu, WA Lawton, ... New England Journal of Medicine 359 (12), 1238-1251, 2008 | 1279 | 2008 |
Pioglitazone after ischemic stroke or transient ischemic attack WN Kernan, CM Viscoli, KL Furie, LH Young, SE Inzucchi, M Gorman, ... New England Journal of Medicine 374 (14), 1321-1331, 2016 | 1204 | 2016 |
Telmisartan to prevent recurrent stroke and cardiovascular events S Yusuf, HC Diener, RL Sacco, D Cotton, S Ôunpuu, WA Lawton, ... New England Journal of Medicine 359 (12), 1225-1237, 2008 | 1049 | 2008 |
European stroke initiative recommendations for stroke management–update 2003 GE Carlsson, A Möller, C Blomstrand, T Ueda, K Mizushige, K Yukiiri, ... Cerebrovascular Diseases 16 (4), 311-337, 2003 | 948 | 2003 |
NXY-059 for acute ischemic stroke KR Lees, JA Zivin, T Ashwood, A Davalos, SM Davis, HC Diener, J Grotta, ... New England Journal of Medicine 354 (6), 588-600, 2006 | 768 | 2006 |
Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry S Sacco, C Marini, D Toni, L Olivieri, A Carolei Stroke 40 (2), 394-399, 2009 | 660 | 2009 |
Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and … RAFS Investigators. Am Heart J 159 (3), 340-347.e1., 2010 | 619 | 2010 |
Risk factors for clinically diagnosed Alzheimer disease: A case-control study of an Italian population LA Amaducci, L Fratiglioni, WA Rocca, C Fieschi, P Livrea, D Pedone, ... Neurology 36, 922-931, 1986 | 554 | 1986 |
Efficacy and safety of Rivaroxaban compared with Warfarin among elderly patients with nonvalvular atrial fibrillation in the ROCKET-AF trial JL Halperin, GJ Hankey, DM Wojdyla, P J.P., Y Lokhnygina, MR Patel, ... Circulation 130, 138-146, 2014 | 499 | 2014 |
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF GJ Hankey, MR Patel, SR Stevens, RC Becker, G Breithardt, A Carolei, ... The Lancet Neurology 11 (4), 315-322, 2012 | 466 | 2012 |
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic … HC Diener, RL Sacco, S Yusuf, D Cotton, S Ôunpuu, WA Lawton, ... The Lancet Neurology 7 (10), 875-884, 2008 | 441 | 2008 |
History of migraine and risk of cerebral ischaemia in young adults A Carolei, C Marini, G De Matteis, ... The Lancet (London, England) 347 (9014), 1503-1506, 1996 | 414 | 1996 |
Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial KR Lees, K Asplund, A Carolei, SM Davis, HC Diener, M Kaste, ... The Lancet 355 (9219), 1949-1954, 2000 | 392 | 2000 |
Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised … A Carolei, TET Investigators" Lancet 385, 617-628, 2015 | 330 | 2015 |
The epidemiology of atrial fibrillation and stroke F Pistoia, S Sacco, C Tiseo, D Degan, R Ornello, A Carolei Cardiology clinics 34 (2), 255-268, 2016 | 327 | 2016 |